Defective pre-implantation embryonic development is a major cause of implantation failure and early embryonic arrest. E1A-associated protein p300 ( p300)/ CREB-binding protein ( CBP ) is known to influence blastocyst formation; however, the molecular mechanisms underlying its role in mouse embryonic development during the 4-cell-to-blastocyst transition remain poorly understood. Here, we show that pharmacological inhibition of p300/CBP markedly reduced morula and blastocyst formation rates, increased embryonic fragmentation, and altered the expression of markers associated with compaction, polarization, and first lineage segregation during the 4-cell-to-blastocyst transition. GO enrichment analysis of the Smart-seq2 data revealed that differentially expressed genes were enriched in biological processes associated with the intrinsic apoptotic signaling pathway in response to DNA damage, cell-cycle regulation, and embryonic development. Consistently, immunofluorescence analyses showed that p300/CBP inhibition promoted DNA damage accumulation, increased apoptosis, and suppressed cell proliferation. Mechanistically, p300/CBP inhibition was associated with reduced histone H1 lysine 75 acetylation (H1K75ac), attenuation of the ataxia telangiectasia mutated (ATM)-associated DNA damage response, impaired DNA repair, DNA damage accumulation, and subsequent p38 MAPK activation. Collectively, these findings support a working model linking these molecular alterations to compromised genome integrity, increased apoptosis, and impaired developmental competence in mouse preimplantation embryos.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: